Sage Therapeutics to Report Second Quarter 2020 Financial Results on Monday, August 10, 2020
July 21 2020 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, today announced it will host a live webcast on Monday,
August 10, 2020, at 8:30 a.m. ET to announce second quarter 2020
financial results and discuss recent business updates.
The webcast can be accessed on the investor page of Sage's
website at investor.sagerx.com. A replay of the webcast will be
available approximately two hours after the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company committed to developing novel therapies
with the potential to transform the lives of people with
debilitating disorders of the brain. We are pursuing new pathways
with the goal of improving brain health, and our depression,
neurology and neuropsychiatry franchise programs aim to change how
brain disorders are thought about and treated. Our mission is to
make medicines that matter so people can get better, sooner. For
more information, please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200721005154/en/
Investor Contact Jeff Boyle 617-949-4256
Jeff.Boyle@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024